0001209191-23-010574.txt : 20230217 0001209191-23-010574.hdr.sgml : 20230217 20230217161610 ACCESSION NUMBER: 0001209191-23-010574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Al-Wakeel Yasir B. CENTRAL INDEX KEY: 0001650691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39592 FILM NUMBER: 23642765 MAIL ADDRESS: STREET 1: MERRIMACK PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQUARE, SUITE B7201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kronos Bio, Inc. CENTRAL INDEX KEY: 0001741830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 781-5200 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001741830 Kronos Bio, Inc. KRON 0001650691 Al-Wakeel Yasir B. C/O KRONOS BIO, INC. 1300 SO. EL CAMINO REAL, SUITE 300 SAN MATEO CA 94402 0 1 0 0 Chief Financial Officer Common Stock 2023-02-15 4 A 0 138911 0.00 A 364745 D Employee Stock Option (Right to Buy) 2.09 2023-02-15 4 A 0 208367 0.00 A 2033-02-14 Common Stock 208367 208367 D Includes an aggregate of 8,993 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on the following dates: 1,478 shares on June 30, 2021, 1,039 shares on December 31, 2021 and 6,476 shares on December 30, 2022. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant. /s/ Allison Frisbee, Attorney-in-Fact 2023-02-17